British Columbia Investment Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,461
| Closed | -$1.1M | – | 838 |
|
|
2022
Q3 | $1.1M | Sell |
4,461
-799
| -15% | -$196K | 0.01% | 620 |
|
|
2022
Q2 | $1.3M | Sell |
5,260
-1,763
| -25% | -$436K | 0.01% | 639 |
|
|
2022
Q1 | $2.33M | Sell |
7,023
-930
| -12% | -$308K | 0.01% | 616 |
|
|
2021
Q4 | $2.86M | Sell |
7,953
-409
| -5% | -$147K | 0.02% | 607 |
|
|
2021
Q3 | $2.72M | Sell |
8,362
-2
| -0% | -$651 | 0.02% | 614 |
|
|
2021
Q2 | $2.61M | Buy |
8,364
+975
| +13% | +$304K | 0.02% | 648 |
|
|
2021
Q1 | $2.36M | Sell |
7,389
-221
| -3% | -$70.4K | 0.02% | 611 |
|
|
2020
Q4 | $2.47M | Sell |
7,610
-188
| -2% | -$60.9K | 0.02% | 592 |
|
|
2020
Q3 | $2.16M | Buy |
7,798
+577
| +8% | +$160K | 0.02% | 568 |
|
|
2020
Q2 | $1.74M | Buy |
7,221
+2,278
| +46% | +$550K | 0.02% | 589 |
|
|
2020
Q1 | $718K | Sell |
4,943
-5,749
| -54% | -$835K | 0.01% | 640 |
|
|
2019
Q4 | $1.82M | Sell |
10,692
-25,015
| -70% | -$4.27M | 0.01% | 697 |
|
|
2019
Q3 | $6.35M | Buy |
35,707
+38
| +0.1% | +$6.76K | 0.06% | 333 |
|
|
2019
Q2 | $9.29M | Buy |
35,669
+18,016
| +102% | +$4.69M | 0.08% | 252 |
|
|
2019
Q1 | $5.04M | Sell |
17,653
-2,265
| -11% | -$647K | 0.04% | 424 |
|
|
2018
Q4 | $6.47M | Sell |
19,918
-5,824
| -23% | -$1.89M | 0.06% | 337 |
|
|
2018
Q3 | $11.6M | Buy |
25,742
+3,482
| +16% | +$1.57M | 0.12% | 186 |
|
|
2018
Q2 | $9.11M | Buy |
+22,260
| New | +$9.11M | 0.08% | 282 |
|